Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 9 of 39, showing 5 Applications out of 191 total, starting on record 41, ending on 45

# Protocol No Study Title Investigator(s) & Site(s) Application Status

41.

ECCT/18/07/03   Development of innovative integrated system to reduce malaria transmission towards elimination in the Lake Victoria basin, Kenya
    Development of innovative integrated system to reduce malaria transmission towards elimination   in the Lake Victoria basin, Kenya   
Principal Investigator(s)
1. WATARU KAGAYA
2. KINYA UCHIHASHI
Site(s) in Kenya
HOMA BAY DISTRICT HOSPITAL
 
Trial Status Analysing
Protocol Date 16-07-2018
View

42.

ECCT/18/07/07   A Randomized, Open, Parallel-group, Single Dose, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel in combination with Ferroquine (FQ) and FQ alone, in African Patients with Unc
    A Randomized, Open label, Parallel-group, Single Dose Regimen, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel (OZ439) given in combination with Ferroquine (FQ) and FQ alone, in African Patients with Uncomplicated Plasmodium falciparum Malaria   
Principal Investigator(s)
1. GRACE KIRINGA KAGUTHI
Site(s) in Kenya
1. Center for Respiratory Diseases Research (Siaya county)
2. KEMRI (Kisumu county)
 
Trial Status (not set!)
Protocol Date 13-11-2017
View

43.

ECCT/18/04/01   CKAF156 STUDY
    A Phase 2 interventional, multicenter, randomized open-label study to determine the effective and tolerable dose of KAF156 and Lumefantrine Solid Dispersion Formulation in combination, given once daily for 1, 2 and 3-days to adults and children with uncomplicated Plasmodium falciparum malaria.   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. KEMRI CDC (Siaya county)
2. Walter Reed Project (Kisumu county)
 
Trial Status Stopped
Protocol Date 14-02-2017
View

44.

ECCT/18/07/01   CCNO17 Male contraception study.
    Clinical Evaluation of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception.       
Principal Investigator(s)
1. Dr John Kinuthia
Site(s) in Kenya
Couples counselling Center
 
Trial Status Recruiting
Protocol Date 04-04-2018
View

45.

ECCT/18/06/01   Safety, Acceptability, and Feasibility of enterade┬« (SAFE)
    Safety, Acceptability, and Feasibility of enterade® in children at risk for environmental enteric dysfunction in Kakamega County, Kenya   
Principal Investigator(s)
1. Michael Benjamin Arndt
2. James Mukabi
Site(s) in Kenya
Kakamega County General Hospital (CGH)
 
Trial Status Completed
Protocol Date 07-05-2018
View